Selective Removal of Macrophages in Atherosclerotic Plaques as a Pharmacological Approach for Plaque Stabilization: Benefits Vs. Potential Complications

Author(s): Valerie Croons, Wim Martinet, Guido R.Y. De Meyer

Journal Name: Current Vascular Pharmacology

Volume 8 , Issue 4 , 2010

Become EABM
Become Reviewer


Atherosclerotic plaque destabilization is a major cause of unstable angina, myocardial infarction, and sudden cardiac death. Macrophages, which are an essential component of unstable plaques, play a pivotal role in the destabilization process, whereas smooth muscle cells contribute to plaque stability. Selective removal of macrophages is therefore an interesting pharmacological objective to stabilize vulnerable, rupture-prone lesions. Pharmacological agents such as clodronate, nitric oxide donors, mammalian target of rapamycin (mTOR) inhibitors, protein synthesis inhibitors, and statins, that are capable of selectively depleting macrophages in atherosclerotic plaques without affecting smooth muscle or endothelial cells, have recently been identified. This review focuses on the mechanism of action of these drugs as well as on the potential pitfalls of drug-induced macrophage depletion.

Keywords: Atherosclerosis, macrophages, smooth muscle cells, cell death

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [495 - 508]
Pages: 14
DOI: 10.2174/157016110791330816
Price: $65

Article Metrics

PDF: 22